Wearable Technology for Dementia Detection and Monitoring

The use of wearable technology is emerging as a promising approach for detecting and monitoring dementia, offering a non-invasive and potentially cost-effective method to assess risk and track disease progression. This technology leverages sensors to capture various physiological data, providing insights into behaviors and changes associated with dementia.

According to www.iAsk.Ai - Ask AI:

Wearable devices, such as smartwatches and activity trackers, are being explored for their potential to identify early signs of dementia by monitoring various health factors.[1] These devices can collect data on physical activity, sleep patterns, heart rate, and other physiological signals.[2]

One area of focus is the measurement of spatial navigation and gait, as these behaviors are often affected early in Alzheimer's disease and other related disorders.[3] Studies have shown that individuals with dementia exhibit lower levels of daily activity, decreased sleep efficiency, and greater intradaily circadian variability compared to healthy controls.[4] These changes can be detected using wearable devices like actigraphs, which are commonly used to measure sleep characteristics.[4]

The ability of wearable devices to continuously monitor physiological measures over extended periods, even in a patient's home, provides unique information not attainable with traditional in-clinic monitoring.[3] This is particularly appealing for dementia populations, as it allows for the collection of ecological valid data in real-world settings.[3]

Researchers are using wearable devices to study ways to prevent delirium, a sudden change in mental abilities that is a risk factor for dementia development.[5] These devices can measure physiological signals like temperature, movement, heart rate, and oxygen levels to gauge the likelihood of a patient developing delirium and be more proactive in treatment.[5]

Wearable devices demonstrate a utility in measuring levels of activity, changes in circadian rhythm, and changes in the sleep wake cycle, which can be used to monitor cognitive changes related to pre-clinical AD.[4]